Aster DM Healthcare profitability ratios
Per cent unless marked ×
| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
Returns | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |||||
|---|---|---|---|---|---|---|
| 9.7% | 9.7% | 134.7% | 2.9% | 10.1% | ||
| 5.8% | 5.8% | 44.0% | 1.3% | 3.5% | ||
| 9.9% | 9.9% | 4.5% | 2.6% | 8.2% | ||
| 9.5% | 9.2% | 9.1% | 5.1% | 10.3% | ||
Margins | ||||||
| 19.6% | 19.4% | 18.5% | 15.6% | 13.1% | ||
| 13.7% | 13.7% | 12.5% | 9.7% | 6.6% | ||
| — | 24.0% | 35.9% | 5.2% | — | ||
| 11.3% | 13.1% | 11.8% | 7.4% | 4.5% | ||
| 7.4% | 9.2% | 130.7% | 5.7% | 4.0% | ||
| 6.5% | 8.4% | 129.9% | 3.5% | 3.6% | ||
| 3.8% | 3.8% | 1.7% | −17.5% | 8.3% | ||
Additional | ||||||
| 27.0% | 23.5% | 27.4% | 20.7% | 11.2% | ||
| — | 12.9% | 114.2% | 8.5% | 5.7% | ||
| 9.7% | 8.4% | −19.1% | 2.6% | 9.5% | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.